Nucleic acid-binding photoprobes and uses thereof
By using small molecule ligands with tethering groups to bind to RNA, identify and regulate RNA binding sites, we solve the delivery and permeability challenges in RNA-mediated disease treatment and achieve precise regulation of RNA transcripts. Provides new treatment avenues.
Patent Information
- Application Number
- CN201880076222.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2017-11-30
- Filing Date
- 2018-11-30
- Publication Date
- 2020-07-07
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing technologies are difficult to effectively identify and regulate the RNA transcriptome, especially in drug delivery, absorption, distribution and cell penetration. The lack of validated small molecule screening methods for RNA targets limits the treatment of RNA-mediated diseases. Effect.
By using small molecule ligands with attachment points for tethering groups to bind to RNA, combined assays identify the binding and active sites of the RNA and modulate the structure and function of the RNA, thereby developing treatments that modulate RNA transcripts. method.
It achieves precise regulation of RNA transcripts, improves drug delivery efficiency and cell permeability, and provides new ways to treat RNA-mediated diseases, especially in the regulation of mRNA, non-coding RNA and repetitive sequence RNA. potential.
